Diatreme Resources Limited

As of December 31, 2025, DIATREME RESOURCES LTD. carries a market capitalization of 64.69M, placing it among publicly traded companies globally. Its enterprise value stands at 63.84M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2025, DIATREME RESOURCES LTD. has 5.01B shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, DIATREME RESOURCES LTD. maintains a current ratio of 1.15, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 1.14, indicating moderate leverage, while an interest coverage ratio of -35.27 demonstrates limited ability to service its debt obligations.

Over the twelve months ended December 31, 2025, DIATREME RESOURCES LTD. posted a negative return on equity (ROE) of -0.80, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -0.78, reflecting losses generated across the asset base.

As of the close on June 26, 2026, DIATREME RESOURCES LTD.'s stock has gained approximately 12400.00% over the past 52 weeks.

These figures cover the twelve months ended December 31, 2025. EBITDA reached -2.00M, while operating income came in at -2.21M.

As of December 31, 2025, DIATREME RESOURCES LTD. holds 1.56M in cash and equivalents against 704,015.09 in total debt, resulting in a net debt position of -882,480.48. Total book value stands at 61.60M, with working capital of 220,076.76 providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield is negative at -0.10, meaning DIATREME RESOURCES LTD. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

DIATREME RESOURCES LTD.'s most recent stock split took place on February 28, 2011 with a 43:44 split ratio.